Gansu Longshenrongfa Pharmaceutical Industry Company Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Public

  • Employees
  • 641

Employees

  • Stock Symbol
  • 300534

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $1.69
  • (As of Thursday Closing)

Gansu Longshenrongfa Pharmaceutical Industry Company General Information

Description

Gansu Longshenrongfa Pharmaceutical Industry Co Ltd is mainly engaged in the pharmaceutical business. It is engaged in the research and development of new drugs, traditional Chinese medicine processing and production. Its products portfolio includes Yuan Hu Zhitong Dripping Pills, Qiwei Wenyang Capsule and Xiaoshuan Tongluo Tablets. Its products are used to adjust gas, promote blood circulation, relieve pain, relieve cough, eliminate phlegm, relieve asthma, clear heat and dispel dampness, among others.

Contact Information

Website
www.lsrfzy.com
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Number 10, Guofang Road, Dingyuan Town
  • Yuzhong County
  • Lanzhou, Gansu 730102
  • China
+86 193
Primary Industry
Pharmaceuticals
Stock Exchange
SHE
Corporate Office
  • Number 10, Guofang Road, Dingyuan Town
  • Yuzhong County
  • Lanzhou, Gansu 730102
  • China
+86 193

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gansu Longshenrongfa Pharmaceutical Industry Company Stock Performance

As of 12-Nov-2026, Gansu Longshenrongfa Pharmaceutical Industry Company’s stock price is $1.69. Its current market cap is $514M with 303M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.69 $1.63 $1.00 - $3.11 $514M 303M 45.8M $0.01

Gansu Longshenrongfa Pharmaceutical Industry Company Financials Summary

As of 30-Sep-2026, Gansu Longshenrongfa Pharmaceutical Industry Company has a trailing 12-month revenue of $103M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 574,823 397,989 343,248 413,875
Revenue 103,046 123,337 145,288 152,660
EBITDA 9,694 17,183 19,055 17,485
Net Income 3,565 6,112 3,411 8,714
Total Assets 195,772 199,308 197,961 188,564
Total Debt 20,773 22,343 18,879 23,642
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Gansu Longshenrongfa Pharmaceutical Industry Company Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Gansu Longshenrongfa Pharmaceutical Industry Company‘s full profile, request access.

Request a free trial

Gansu Longshenrongfa Pharmaceutical Industry Company Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Gansu Longshenrongfa Pharmaceutical Industry Company Investments & Acquisitions (3)

Gansu Longshenrongfa Pharmaceutical Industry Company’s most recent deal was a Merger/Acquisition with Gansu Pharmaceutical Group Science and Technology Research Institute for . The deal was made on 29-Mar-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Gansu Pharmaceutical Group Science and Technology Research Institute 29-Mar-2025 Merger/Acquisition Other Pharmaceuticals and Biotechnology
Puan Pharmaceutical 01-Feb-2023 Merger/Acquisition Drug Discovery
China Dragon Securities Company 21-Dec-2016 PE Growth/Expansion Brokerage
To view Gansu Longshenrongfa Pharmaceutical Industry Company’s complete investments and acquisitions history, request access »

Gansu Longshenrongfa Pharmaceutical Industry Company ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Gansu Longshenrongfa Pharmaceutical Industry Company’s complete esg history, request access »

Gansu Longshenrongfa Pharmaceutical Industry Company Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Gansu Pharmaceutical Group Science and Technology Research Institute Lanzhou, China 2020
Puan Pharmaceutical Wuwei, China 2004

Gansu Longshenrongfa Pharmaceutical Industry Company FAQs

  • When was Gansu Longshenrongfa Pharmaceutical Industry Company founded?

    Gansu Longshenrongfa Pharmaceutical Industry Company was founded in 2002.

  • Where is Gansu Longshenrongfa Pharmaceutical Industry Company headquartered?

    Gansu Longshenrongfa Pharmaceutical Industry Company is headquartered in Lanzhou, China.

  • What is the size of Gansu Longshenrongfa Pharmaceutical Industry Company?

    Gansu Longshenrongfa Pharmaceutical Industry Company has 641 total employees.

  • What industry is Gansu Longshenrongfa Pharmaceutical Industry Company in?

    Gansu Longshenrongfa Pharmaceutical Industry Company’s primary industry is Pharmaceuticals.

  • Is Gansu Longshenrongfa Pharmaceutical Industry Company a private or public company?

    Gansu Longshenrongfa Pharmaceutical Industry Company is a Public company.

  • What is Gansu Longshenrongfa Pharmaceutical Industry Company’s stock symbol?

    The ticker symbol for Gansu Longshenrongfa Pharmaceutical Industry Company is 300534.

  • What is the current stock price of Gansu Longshenrongfa Pharmaceutical Industry Company?

    As of 12-Nov-2026 the stock price of Gansu Longshenrongfa Pharmaceutical Industry Company is $1.69.

  • What is the current market cap of Gansu Longshenrongfa Pharmaceutical Industry Company?

    The current market capitalization of Gansu Longshenrongfa Pharmaceutical Industry Company is $514M.

  • What is Gansu Longshenrongfa Pharmaceutical Industry Company’s current revenue?

    The trailing twelve month revenue for Gansu Longshenrongfa Pharmaceutical Industry Company is $103M.

  • What is Gansu Longshenrongfa Pharmaceutical Industry Company’s annual earnings per share (EPS)?

    Gansu Longshenrongfa Pharmaceutical Industry Company’s EPS for 12 months was $0.01.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process